Skip to main content
Top

04-04-2024 | Aplastic Anemia | Clinical Report

Successful Treatment of Severe Aplastic Anemia with Hematopoietic Stem Cell Transplantation in the Setting of Active Mucormycosis

Authors: Suleimen Zhumatayev, Safiye Suna Celen, Manolya Kara, Ayse Adin Selcuk, Betül Bozkurt, Mustafa Kemal Demir, Koray Yalcın

Published in: Indian Journal of Otolaryngology and Head & Neck Surgery

Login to get access

Abstract

Severe aplastic anemia (SAA) is a life-threatening hematological disease characterized by the suppression of the bone marrow. Patients with SAA are predisposed to recurrent bacterial infections and invasive fungal infections (IFI) due to profound and persistent neutropenia. Mucorales are the second most common cause of IFI encountered in SAA. Here we present a pediatric case of SAA with active mucormycosis infection of the paranasal sinuses. In the first step, surgical debridement was performed and combined antifungal therapy (liposomal amphotericin B, posaconazole, caspofungin) was started. Due to severe neutropenia, daily granulocyte transfusion was added to therapy. Hyperbaric oxygen therapy was applied for wound healing. After all this the patient went under flap surgery. One week after the successful flap procedure, HSCT was performed and he had no complications related to HSCT. The patient was followed in the outpatient clinic for 6 months with posaconazole. Now, he is out of drugs and followed without problems for 15 months after HSCT. Our case confirms that urgent HSCT with multiple therapies (surgical debridement, granulocyte support, combined antifungal therapy, hyperbaric O2) is crucial for saving life in SAA patients with active mucormycosis.
Literature
2.
go back to reference Dufour C, Pillon M, Socie G, Rovo A, Carraro E, Bacigalupo A et al (2015) Outcome of aplastic anemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant. Br J Haematol 169(4):565–573CrossRefPubMed Dufour C, Pillon M, Socie G, Rovo A, Carraro E, Bacigalupo A et al (2015) Outcome of aplastic anemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant. Br J Haematol 169(4):565–573CrossRefPubMed
3.
go back to reference Valdez JM, Scheinberg P, Young NS, Walsh TJ (2009) Infections in patients with aplastic anemia. Semin Hematol 46(3):269–276CrossRefPubMed Valdez JM, Scheinberg P, Young NS, Walsh TJ (2009) Infections in patients with aplastic anemia. Semin Hematol 46(3):269–276CrossRefPubMed
4.
go back to reference Armstrong D (1993) Treatment of opportunistic fungal infections. Clin Infect Dis Off Publ Infect Dis Soc Am 16(1):1–7CrossRef Armstrong D (1993) Treatment of opportunistic fungal infections. Clin Infect Dis Off Publ Infect Dis Soc Am 16(1):1–7CrossRef
5.
go back to reference Bacigalupo A, Socie G, Lanino E, Prete A, Locatelli F, Locasciulli A et al (2010) Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party. Haematologica 95(6):976–982CrossRefPubMedPubMedCentral Bacigalupo A, Socie G, Lanino E, Prete A, Locatelli F, Locasciulli A et al (2010) Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party. Haematologica 95(6):976–982CrossRefPubMedPubMedCentral
6.
go back to reference Zhu Y, Gao Q, Hu J, Liu X, Guan D, Zhang F (2020) Allo-HSCT compared with immunosuppressive therapy for acquired aplastic anemia: a system review and meta-analysis. BMC Immunol 21(1):10CrossRefPubMedPubMedCentral Zhu Y, Gao Q, Hu J, Liu X, Guan D, Zhang F (2020) Allo-HSCT compared with immunosuppressive therapy for acquired aplastic anemia: a system review and meta-analysis. BMC Immunol 21(1):10CrossRefPubMedPubMedCentral
7.
go back to reference Doni BR, Peerapur BV, Thotappa LH, Hippargi SB (2011) Sequence of oral manifestations in rhino-maxillary mucormycosis. Indian J Dent Res Off Publ Indian Soc Dent Res 22(2):331–335CrossRef Doni BR, Peerapur BV, Thotappa LH, Hippargi SB (2011) Sequence of oral manifestations in rhino-maxillary mucormycosis. Indian J Dent Res Off Publ Indian Soc Dent Res 22(2):331–335CrossRef
8.
go back to reference Blitzer A, Lawson W, Meyers BR, Biller HF (1980) Patient survival factors in paranasal sinus mucormycosis. Laryngoscope 90(4):635–648CrossRefPubMed Blitzer A, Lawson W, Meyers BR, Biller HF (1980) Patient survival factors in paranasal sinus mucormycosis. Laryngoscope 90(4):635–648CrossRefPubMed
9.
go back to reference Young RF, Gade G, Grinnell V (1985) Surgical treatment for fungal infections in the central nervous system. J Neurosurg 63(3):371–381CrossRefPubMed Young RF, Gade G, Grinnell V (1985) Surgical treatment for fungal infections in the central nervous system. J Neurosurg 63(3):371–381CrossRefPubMed
Metadata
Title
Successful Treatment of Severe Aplastic Anemia with Hematopoietic Stem Cell Transplantation in the Setting of Active Mucormycosis
Authors
Suleimen Zhumatayev
Safiye Suna Celen
Manolya Kara
Ayse Adin Selcuk
Betül Bozkurt
Mustafa Kemal Demir
Koray Yalcın
Publication date
04-04-2024